AIMEE HERRINGTON: Open Payments
NPI 1275806911 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 72 payments from 16 companies in 2025. Trend: 2023 $960 · 2024 $2,152 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $248 |
| Dexcom, Inc. | 5 | $209 |
| Novo Nordisk Inc | 17 | $202 |
| Corcept Therapeutics | 8 | $186 |
| Insulet Corporation | 15 | $175 |
| Radius Health, Inc. | 2 | $144 |
| Mannkind Corporation | 4 | $93 |
| Abbott Laboratories | 3 | $70 |
| Lilly USA, LLC | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
Products named: MINIMED 780G, Korlym, Omnipod, Tymlos, DEXCOM G7 GSS (161), Ozempic, AFREZZA, Rybelsus.
Industry payments across FL — which companies pay providers there.
